PHARMA-BIO SERV, INC. Payments to Acquire Marketable Securities
PHARMA-BIO SERV, INC. (PBSV) reported Payments to Acquire Marketable Securities of $4.76 million for the 3-month period ending 2024-01-31, per its 10-Q filed 2024-03-18.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-03-18
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for the quarter ending 2024-01-31 was $4.76M, a 41.89% decline year-over-year.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for the quarter ending 2023-10-31 was -$7.33M.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for the quarter ending 2023-07-31 was $6.18M.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for the quarter ending 2023-01-31 was $8.20M.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for fiscal 2023 was $4.21M.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for fiscal 2022 was $0.00.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- PHARMA-BIO SERV, INC. payments to acquire marketable securities for fiscal 2010 was $95.00K.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-01-31 | $4.76M 10-Q · filed 2024-03-18 | -$2.56M derived: sum of 2 quarters · filed 2024-03-18 | $3.61M derived: sum of 3 quarters · filed 2024-03-18 | |
| 2023-10-31 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-29 | -$1.15M derived: sum of 2 quarters · filed 2024-01-29 | $4.21M 10-K · filed 2024-01-29 | |
| 2023-07-31 | $6.18M 10-Q · filed 2023-09-14 | $11.54M 10-Q · filed 2023-09-14 | ||
| 2023-01-31 | $8.20M 10-Q · filed 2024-03-18 | $8.20M derived: sum of 2 quarters · filed 2024-03-18 | $8.20M derived: sum of 3 quarters · filed 2024-03-18 | |
| 2022-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-29 | $0.00 derived: sum of 2 quarters · filed 2024-01-29 | $0.00 10-K · filed 2024-01-29 | |
| 2022-07-31 | $0.00 10-Q · filed 2023-09-14 | $0.00 10-Q · filed 2023-09-14 | ||
| 2011-10-31 | $0.00 10-K/A · filed 2012-01-31 | |||
| 2010-10-31 | $95.00K 10-K/A · filed 2012-01-31 |